Stem cell culture and bioprocessing

Getting cell therapy products onto the market as quickly as possible still remains a key driver in the improvement of recombinant therapeutic proteins. Any such advance in bioprocessing is of particular interest to the industry if it considerably shortens the development timeline or improves the end product. In the monoclonal antibody (MAb) area, platform procedures have allowed companies to regulate on particular mammalian cell lines, transfection approaches, process conditions and also downstream processing to shorten the development timeline.

  • Bioprocessing techniques used in stem cell culture
  • Micro fluids in cell therapy
  • DNA vaccines
  • Molecular manufacturing
  • Current understanding & challenges in bioprocessing

Quick Links

Are you interested in

Mail us at

Program enquiry
Sponsorship oportunity
General queries
More details about
Copyright © 2018-2019 Allied Academies, All Rights Reserved.